dorzolamide hydrochloride

dorzolamide hydrochloride

[dorzo′lämīd]
a carbonic acid anhydrase inhibitor used in treatment of open-angle glaucoma and ocular hypertension, administered topically to the conjunctiva as the hydrochloride salt.
indications It is prescribed in the treatment of glaucoma. It reduces intraocular pressure by decreasing the rate of fluid production.
contraindications It should not be given to patients wearing soft contact lenses or those with allergy to dorzolamide or its components or related substances.
adverse effects The side effects most often reported include ocular burning, stinging or discomfort following use; tearing; blurred vision; or light sensitivity.
Mentioned in ?
References in periodicals archive ?
Tenders are invited for Eye Drop Dorzolamide Hydrochloride 2 Percent, 5 Ml
We then added 2% dorzolamide hydrochloride twice a day to the therapy.
has received approval from the Food and Drug Administration of its ANDA for dorzolamide hydrochloride and timolol maleate ophthalmic solution, 2%/0.
Pharmaceutical company Lannett Company (NYSE:LCI) reported on Thursday that it has received approval from the US Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Dorzolamide Hydrochloride and Timolol Maleate Ophthalmic Solution, 2%/0.
The company stated that Dorzolamide Hydrochloride and Timolol Maleate Ophthalmic Solution, 2%/0.
Effects of topical 2% dorzolamide hydrochloride alone and in combination with 0.
MASON, Ohio -- Prasco announced today it has begun shipping generic forms of Dorzolamide Hydrochloride-Timolol Maleate and Dorzolamide Hydrochloride Ophthalmic Solutions, comparable to Merck's COSOPT([R]) and TRUSOPT([R]).
Dorzolamide hydrochloride-timolol maleate and dorzolamide hydrochloride ophthalmic solutions are indicated for the treatment of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension.
In October 2008 Hi-Tech was granted final approval for dorzolamide hydrochloride ophthalmic solution and dorzolamide hydrochloride with timolol maleate ophthalmic solution, generic equivalents of Merck & Co.
NASDAQ: HITK) announced today that the US Food and Drug Administration (FDA) has granted tentative approval to the Company's Abbreviated New Drug Application (ANDA) for dorzolamide hydrochloride with timolol maleate ophthalmic solution.
TRUSOPT Sterile Ophthalmic Solution is supplied as a sterile, isotonic, buffered, slightly viscous, aqueous solution of dorzolamide hydrochloride.
April 2008--Hi-Tech Pharmacal was granted tentative approval for dorzolamide hydrochloride with timolol maleate ophthalmic solution.